Table 13.

Main maternal and infant outcomes in metformin treated women with T2DM

	Maternal outcomes	Infant outcomes
Type 2 diabetes	Reduced maternal weight gain Decreased risk of maternal hypoglycemia Better metabolic control during the later stages of pregnancy	Decreased risk of neonatal hypoglycemia Decreased LGA and reduced body fat of neonates Increased risk for SGA in women with comorbidities as chronic hypertension or nephropathy in pregnancy 2 years old children have similar BMI Z score and skinfolds thickness